Charting the course:
The impact of genomics on drug development

This webinar features host Patrick Short in conversation with David Ochoa, Platform Coordinator at Open Targets, an innovative public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation. The discussion explores the role of human genetics in drug target identification, types of datasets used, target safety, and intervention strategies, along with the evolving landscape of drug modalities and future research directions. Patrick and David discuss challenges, opportunities, and potential impact of genomic data in drug discovery.


Our panel of experts


Patrick Short-4

Patrick Short

Co-Founder & CEO
Sano Genetics

david ochoa

David Ochoa

Platform Coordinator
Open Targets